Abstract
The genetic etiology of autism spectrum disorder (ASD) is multifactorial with contributions from rare variants, polygenic risk, and sex. How combinations of factors determine risk for ASD is unclear. In 11,313 ASD families (N = 37,375 subjects), we investigated the effects rare and polygenic risk individually and in combination. We show that genetic liability for ASD differs by sex, with females having a greater polygenic load, and males having a lower liability threshold as evident by a negative correlation of rare and polygenic risk. Multiple genetic factors were associated with differing sets of behavioral traits with effects that differed by sex. Furthermore, the correlation of parental age with genetic risk for ASD was attributable to de novo mutations and sex-biased effects of inherited risk in parents. Our results demonstrate that a phenotypic spectrum of ASD is attributable to the relative loadings and gene-by-sex effects of rare and common variation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by grants to J.S. from the Simons Foundation Autism Research initiative (SFARI 606768), National Institutes of Health (MH113715, MH119746, 1MH109501) and the Escher fund for Autism (20171603) and grant to C.N. from the National Institutes of Health (MH106595). D.A. was supported by A T32 training grant from the NIH (GM008666). M.K. was supported by a Rubicon grant from the Netherlands Organization for Scientific Research (NOW 45219212).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was carried out as part of protocol 101413 approved by the Institutional Review Board of the UCSD Human Research Protections Program
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
WGS data from the SSC and Exome and SNP genotyping data from SPARK are available from the Simons Foundation Autism Research Initiative (SFARI) Summary genetic data including individual counts for dnLoF, dnMis, inhLoF and polygenic scores for all subjects in this study and input data files for all analysis code are also available from SFARI. WGS data from the REACH project are available from the NIMH Data Archive (NDA) including the structural variant callset, and raw sequence (FASTQ), alignment (BAM) and variant call (VCF) files from the REACH cohort. Analysis code for the major statistical genetic analyses in the paper is available as a Google Colab notebook on Github https://github.com/sebatlab/Antaki2021. Analysis code is provided for the following. Variance Explained by Genetic Risk Factors (Fig 2A) Negative correlations of rare and common genetic risk (Fig. 3) Gene/phenotype correlations (Fig. 5)
